Filaggrin mutations and atopy: consequences for future therapeutics (Q37979847)

26 August 2017

Filaggrin mutations and atopy: consequences for future therapeutics (English)

1 reference

26 August 2017

2

1 reference

26 August 2017

Jennifer Heimall

1

1 reference

26 August 2017

1 February 2012

1 reference

Expert Review of Clinical Immunology

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

2

1 reference

26 August 2017

189-197

1 reference

Filaggrin in atopic dermatitis.

26 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Moisturization and skin barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Filaggrin mutations associated with skin and allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

The immunogenetics of asthma and eczema: a new focus on the epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Cytokine modulation of atopic dermatitis filaggrin skin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Atopic dermatitis and the atopic march

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

The natural course of atopic dermatitis from birth to age 7 years and the association with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Sensing the outside world: TSLP regulates barrier immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Factors associated with the development of peanut allergy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Recent insights into atopic dermatitis and implications for management of infectious complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Filaggrin in the frontline: role in skin barrier function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Eczema genetics: current state of knowledge and future goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Skin Barrier Function in Healthy Subjects and Patients with Atopic Dermatitis in Relation to Filaggrin Loss-of-Function Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Clinical Severity Correlates with Impaired Barrier in Filaggrin-Related Eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FECI.11.100

21 January 2018

Identifiers

DOI

10.1586/ECI.11.100

1 reference

26 August 2017

1 reference

PubMed ID

22288457